Risk factors for fatal and non-fatal cardiovascular events in 9306 subjects in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

被引：0

作者：

Mcmurray, J. J. V. ^{[1
]}

Laakso, M. ^{[2
]}

Standl, E. ^{[3
]}

Tognoni, G. ^{[4
]}

Holman, R. R. ^{[5
]}

Giles, T. ^{[6
]}

Martinez, F. ^{[7
]}

Thomas, L. ^{[8
]}

Haffner, S. M.

Califf, R. M. ^{[9
]}

机构：

[1] British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland

[2] Kuopio Univ Hosp, SF-70210 Kuopio, Finland

[3] Munich Diabet Res Grp, Diabet Res Inst, Munich, Germany

[4] Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands

[5] Oxford Ctr Diabet Endocrinol & Metab, Diabet Trials Unit, Oxford, England

[6] Tulane Univ, Heart & Vasc Inst, New Orleans, LA 70118 USA

[7] Natl Univ Cordoba, Cordoba, Argentina

[8] Duke Clin Res Inst, Durham, NC USA

[9] Duke Translat Med Inst, Durham, NC USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：287 / 287

页数：1